| The ckrScreen is a rapid screen for antipsychotic efficacy based on chakragati mouse model. This US-patented, transgenic model of dopamine dysfunction closely correlates with important behavioural, anatomical and pharmacological changes also reported in schizophrenia patients. The ckrScreen gives fast readouts of efficacy and effective dose based on multiple behavioural outputs.
We believe our ckrScreen gives the deepest insights into the clinical efficacy of potential broad-spectrum antipsychotic compounds. To talk to us about how the ckrScreen can help your discovery program please contact us through webinfo@chakrabiotech.com.my. |
| |
We offer a range of standard neurobehavioural screens. These can be accessed through  AssayDepot.com. |
| |
| Chakra Biotech has automated our neurobehavioural screening using state-of-the-art test platforms. |
| |
| 1) |
Laboras Home Activity Monitoring: neurobehavioural assays with increased efficiency, quality (objectivity) and throughput. |
|
|
| 2) |
Noldus Ethovision® XT system: automated tracking and data analysis of neurobehavioural assays. |
|
|
| 3) |
Laboras SonoTrack®: recording and analysis of ultra vocalizations to test stress, anxiety, pain and social interactions. |
|
|
|
